

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.65559536 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.65559536 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.30101648 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.30101648 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.98067710 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.96195253 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.40875764 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.40875764 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.40875764 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30883847 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.25601979 |
| 12 | urea metabolic process (GO:0019627) | 5.24941112 |
| 13 | urea cycle (GO:0000050) | 5.24941112 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.21786431 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.12547333 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.06226729 |
| 17 | protein carboxylation (GO:0018214) | 5.05475504 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05475504 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.04488381 |
| 20 | regulation of protein activation cascade (GO:2000257) | 5.00684733 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00340594 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.98473662 |
| 23 | reverse cholesterol transport (GO:0043691) | 4.98074943 |
| 24 | phospholipid efflux (GO:0033700) | 4.92623314 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.85971460 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.80152498 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.79431485 |
| 28 | cysteine metabolic process (GO:0006534) | 4.71707810 |
| 29 | regulation of complement activation (GO:0030449) | 4.70635065 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.68297965 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 4.66871330 |
| 32 | glucocorticoid biosynthetic process (GO:0006704) | 4.66782629 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.65836476 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.60926545 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.60926545 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.60926545 |
| 37 | bile acid metabolic process (GO:0008206) | 4.51442211 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.45326959 |
| 39 | acylglycerol homeostasis (GO:0055090) | 4.43889084 |
| 40 | triglyceride homeostasis (GO:0070328) | 4.43889084 |
| 41 | plasma lipoprotein particle assembly (GO:0034377) | 4.38798838 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 4.37577691 |
| 43 | cholesterol efflux (GO:0033344) | 4.36038943 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 4.34571832 |
| 45 | bile acid and bile salt transport (GO:0015721) | 4.31586530 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.30312538 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.24194757 |
| 48 | phospholipid homeostasis (GO:0055091) | 4.21336167 |
| 49 | thrombin receptor signaling pathway (GO:0070493) | 4.20697092 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.20638559 |
| 51 | lysine metabolic process (GO:0006553) | 4.17084165 |
| 52 | lysine catabolic process (GO:0006554) | 4.17084165 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.11528138 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.11528138 |
| 55 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.98450514 |
| 56 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.98450514 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 3.95395982 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93045538 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 3.92543250 |
| 60 | amine catabolic process (GO:0009310) | 3.92543250 |
| 61 | protein-lipid complex assembly (GO:0065005) | 3.92486494 |
| 62 | epoxygenase P450 pathway (GO:0019373) | 3.91088141 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 3.90111701 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.88028607 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.83595210 |
| 66 | plasma lipoprotein particle organization (GO:0071827) | 3.82144491 |
| 67 | fibrinolysis (GO:0042730) | 3.81981879 |
| 68 | exogenous drug catabolic process (GO:0042738) | 3.79202876 |
| 69 | cellular glucuronidation (GO:0052695) | 3.76308560 |
| 70 | regulation of cholesterol homeostasis (GO:2000188) | 3.75284806 |
| 71 | cholesterol homeostasis (GO:0042632) | 3.75070365 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73320393 |
| 73 | sterol homeostasis (GO:0055092) | 3.69226586 |
| 74 | lipoprotein metabolic process (GO:0042157) | 3.68940117 |
| 75 | glucocorticoid metabolic process (GO:0008211) | 3.66317319 |
| 76 | drug catabolic process (GO:0042737) | 3.66066842 |
| 77 | glutamate metabolic process (GO:0006536) | 3.64841833 |
| 78 | angiotensin maturation (GO:0002003) | 3.64257132 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 3.63565647 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.62488052 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.62098731 |
| 82 | complement activation (GO:0006956) | 3.61919060 |
| 83 | protein activation cascade (GO:0072376) | 3.60271553 |
| 84 | complement activation, classical pathway (GO:0006958) | 3.59803683 |
| 85 | protein-lipid complex subunit organization (GO:0071825) | 3.58908571 |
| 86 | blood coagulation, intrinsic pathway (GO:0007597) | 3.58620590 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.56960794 |
| 88 | arginine metabolic process (GO:0006525) | 3.56188965 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.55300119 |
| 90 | negative regulation of lipase activity (GO:0060192) | 3.54107699 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.52458434 |
| 92 | androgen biosynthetic process (GO:0006702) | 3.46379282 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.43341768 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.43341768 |
| 95 | progesterone metabolic process (GO:0042448) | 3.43254386 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.41913990 |
| 97 | cofactor catabolic process (GO:0051187) | 3.41739650 |
| 98 | definitive hemopoiesis (GO:0060216) | 3.40837650 |
| 99 | glycine metabolic process (GO:0006544) | 3.38885088 |
| 100 | serine family amino acid metabolic process (GO:0009069) | 3.36702230 |
| 101 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.33765979 |
| 102 | ethanol oxidation (GO:0006069) | 3.32817882 |
| 103 | coenzyme catabolic process (GO:0009109) | 3.32382461 |
| 104 | drug transmembrane transport (GO:0006855) | 3.31648597 |
| 105 | acute-phase response (GO:0006953) | 3.31220935 |
| 106 | response to nitrosative stress (GO:0051409) | 3.30183491 |
| 107 | intestinal cholesterol absorption (GO:0030299) | 3.29080828 |
| 108 | ketone body metabolic process (GO:1902224) | 3.28611692 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.27932155 |
| 110 | organic acid catabolic process (GO:0016054) | 3.27932155 |
| 111 | hormone catabolic process (GO:0042447) | 3.27751274 |
| 112 | neutrophil activation involved in immune response (GO:0002283) | 3.18518525 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 3.17382919 |
| 114 | intestinal absorption (GO:0050892) | 3.13825775 |
| 115 | peptide catabolic process (GO:0043171) | 3.11998847 |
| 116 | negative regulation of complement activation (GO:0045916) | 3.09298157 |
| 117 | drug metabolic process (GO:0017144) | 3.07388951 |
| 118 | ethanol metabolic process (GO:0006067) | 3.04052311 |
| 119 | daunorubicin metabolic process (GO:0044597) | 3.02481633 |
| 120 | polyketide metabolic process (GO:0030638) | 3.02481633 |
| 121 | doxorubicin metabolic process (GO:0044598) | 3.02481633 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98240265 |
| 123 | C21-steroid hormone metabolic process (GO:0008207) | 2.93349998 |
| 124 | negative regulation of blood coagulation (GO:0030195) | 2.85074494 |
| 125 | negative regulation of hemostasis (GO:1900047) | 2.85074494 |
| 126 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.83555993 |
| 127 | hemoglobin metabolic process (GO:0020027) | 2.77944087 |
| 128 | cyclooxygenase pathway (GO:0019371) | 2.77813561 |
| 129 | positive regulation of hemostasis (GO:1900048) | 2.75614409 |
| 130 | positive regulation of blood coagulation (GO:0030194) | 2.75614409 |
| 131 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.71091749 |
| 132 | regulation of humoral immune response (GO:0002920) | 2.67551366 |
| 133 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.67097479 |
| 134 | negative regulation of humoral immune response (GO:0002921) | 2.64387566 |
| 135 | positive regulation of coagulation (GO:0050820) | 2.62063484 |
| 136 | androgen metabolic process (GO:0008209) | 2.61535462 |
| 137 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.61098266 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.58862579 |
| 139 | negative regulation of coagulation (GO:0050819) | 2.58545050 |
| 140 | leukotriene metabolic process (GO:0006691) | 2.58409747 |
| 141 | regulation of platelet activation (GO:0010543) | 2.58183513 |
| 142 | alkaloid metabolic process (GO:0009820) | 2.53357049 |
| 143 | antibacterial humoral response (GO:0019731) | 2.52953953 |
| 144 | regulation of hemostasis (GO:1900046) | 2.49848325 |
| 145 | regulation of blood coagulation (GO:0030193) | 2.49848325 |
| 146 | lipoprotein transport (GO:0042953) | 2.48330390 |
| 147 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.47934991 |
| 148 | flavonoid metabolic process (GO:0009812) | 2.46369573 |
| 149 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.45736281 |
| 150 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.45736281 |
| 151 | endocrine process (GO:0050886) | 2.45736281 |
| 152 | positive regulation of steroid metabolic process (GO:0045940) | 2.45534795 |
| 153 | phenylpropanoid metabolic process (GO:0009698) | 2.44328204 |
| 154 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.43690076 |
| 155 | arginine catabolic process (GO:0006527) | 2.42883810 |
| 156 | xenobiotic metabolic process (GO:0006805) | 2.42360068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.47164818 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.52514805 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.36547175 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.06954603 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.61192713 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.60332433 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11315345 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.65932044 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.56978262 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.15609529 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10803016 |
| 12 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.10150907 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08773763 |
| 14 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5174314 |
| 15 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.98926402 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98235660 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87058890 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85605883 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82276675 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81136082 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80899673 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74416096 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69307367 |
| 24 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66452199 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66256999 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65607789 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51918484 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30982708 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.28225752 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26590228 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25392883 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24637839 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23453223 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22119301 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19748417 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19352620 |
| 37 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15899861 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15623685 |
| 39 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14544749 |
| 40 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13296184 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12543713 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10617197 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10184179 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09870266 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09437251 |
| 46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08487088 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07165720 |
| 48 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.07022881 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05649503 |
| 50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00982716 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00607657 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99921706 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99058464 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97554313 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95696762 |
| 56 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95309216 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93949257 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92999969 |
| 59 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92548285 |
| 60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.91256441 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90041946 |
| 62 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89807722 |
| 63 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88678820 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87344492 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86998549 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.86467088 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86334943 |
| 68 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86312508 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86150327 |
| 70 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.85619776 |
| 71 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85355176 |
| 72 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85355176 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85161354 |
| 74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83887144 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83020182 |
| 76 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81617462 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81431645 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81299623 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80851217 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80500391 |
| 81 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80425062 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79882595 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77907119 |
| 84 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76547611 |
| 85 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76405124 |
| 86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75888155 |
| 87 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73807797 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.73698461 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73648815 |
| 90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71743605 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70933558 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.69838203 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69379727 |
| 94 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67275931 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66847115 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66470983 |
| 97 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65048601 |
| 98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64448386 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62914177 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.61488000 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58681847 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.58488946 |
| 103 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57797121 |
| 104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56660359 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.56052193 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54295596 |
| 107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53865404 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53533326 |
| 109 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.53501959 |
| 110 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.53424416 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.53237287 |
| 112 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.52327157 |
| 113 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.51958186 |
| 114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51807978 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.51049199 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.50711345 |
| 117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50710023 |
| 118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50533465 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49542025 |
| 120 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49255327 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49223938 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.49209381 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48969330 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.48501125 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48136565 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.47369474 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.46216702 |
| 128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46196568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.67411268 |
| 2 | MP0005360_urolithiasis | 6.65846106 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.71205483 |
| 4 | MP0005365_abnormal_bile_salt | 5.61392730 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33600050 |
| 6 | MP0003252_abnormal_bile_duct | 3.63927535 |
| 7 | MP0008004_abnormal_stomach_pH | 3.56987288 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.46628362 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.37299623 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 3.35900654 |
| 11 | MP0009840_abnormal_foam_cell | 3.14047448 |
| 12 | MP0005083_abnormal_biliary_tract | 2.60231170 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59947960 |
| 14 | MP0000465_gastrointestinal_hemorrhage | 2.59715745 |
| 15 | MP0003195_calcinosis | 2.55154296 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.38661692 |
| 17 | MP0005332_abnormal_amino_acid | 2.36523491 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.06882330 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.01651424 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.90290146 |
| 21 | MP0010155_abnormal_intestine_physiology | 1.83450383 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.79747290 |
| 23 | MP0009697_abnormal_copulation | 1.70396987 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.70266759 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.70266759 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.63436721 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.60154828 |
| 28 | MP0003868_abnormal_feces_composition | 1.57025106 |
| 29 | MP0001764_abnormal_homeostasis | 1.56244138 |
| 30 | MP0001664_abnormal_digestion | 1.49136395 |
| 31 | MP0002254_reproductive_system_inflammat | 1.44907342 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.38522637 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32702238 |
| 34 | MP0001765_abnormal_ion_homeostasis | 1.28802384 |
| 35 | MP0009764_decreased_sensitivity_to | 1.28068609 |
| 36 | MP0003866_abnormal_defecation | 1.27895693 |
| 37 | MP0003186_abnormal_redox_activity | 1.27465524 |
| 38 | MP0005451_abnormal_body_composition | 1.22084641 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.21146017 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.17413878 |
| 41 | MP0000598_abnormal_liver_morphology | 1.17016421 |
| 42 | MP0000604_amyloidosis | 1.16706439 |
| 43 | MP0003436_decreased_susceptibility_to | 1.13406195 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.12114850 |
| 45 | MP0008469_abnormal_protein_level | 1.11721960 |
| 46 | MP0008775_abnormal_heart_ventricle | 1.09212030 |
| 47 | MP0009763_increased_sensitivity_to | 1.08652373 |
| 48 | * MP0005636_abnormal_mineral_homeostasis | 1.08534009 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.07553963 |
| 50 | MP0001851_eye_inflammation | 1.07242708 |
| 51 | MP0002132_abnormal_respiratory_system | 1.07081789 |
| 52 | MP0003011_delayed_dark_adaptation | 1.05870727 |
| 53 | MP0005408_hypopigmentation | 1.05662592 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.03736178 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.02995892 |
| 56 | MP0005647_abnormal_sex_gland | 1.02133472 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.00916372 |
| 58 | MP0003724_increased_susceptibility_to | 1.00574357 |
| 59 | MP0005387_immune_system_phenotype | 0.99501793 |
| 60 | MP0001790_abnormal_immune_system | 0.99501793 |
| 61 | MP0001663_abnormal_digestive_system | 0.99213347 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 0.97773486 |
| 63 | MP0004147_increased_porphyrin_level | 0.96916663 |
| 64 | MP0005165_increased_susceptibility_to | 0.92224283 |
| 65 | MP0004484_altered_response_of | 0.92042281 |
| 66 | * MP0009642_abnormal_blood_homeostasis | 0.91003190 |
| 67 | MP0005409_darkened_coat_color | 0.90567703 |
| 68 | MP0005000_abnormal_immune_tolerance | 0.89356498 |
| 69 | MP0002396_abnormal_hematopoietic_system | 0.89096266 |
| 70 | MP0001800_abnormal_humoral_immune | 0.84680050 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.84125990 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.83078417 |
| 73 | MP0001756_abnormal_urination | 0.81339827 |
| 74 | MP0000343_altered_response_to | 0.81299426 |
| 75 | MP0003828_pulmonary_edema | 0.78401285 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.78196200 |
| 77 | MP0003879_abnormal_hair_cell | 0.77653748 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 0.77109898 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.76894432 |
| 80 | MP0002723_abnormal_immune_serum | 0.76285721 |
| 81 | MP0008872_abnormal_physiological_respon | 0.75962230 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.74883718 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.74375783 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.73283843 |
| 85 | MP0002928_abnormal_bile_duct | 0.72959383 |
| 86 | MP0001853_heart_inflammation | 0.72611354 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.72166193 |
| 88 | * MP0002419_abnormal_innate_immunity | 0.72115852 |
| 89 | MP0005670_abnormal_white_adipose | 0.72013465 |
| 90 | MP0003303_peritoneal_inflammation | 0.70900699 |
| 91 | MP0003690_abnormal_glial_cell | 0.70841833 |
| 92 | MP0002971_abnormal_brown_adipose | 0.70353924 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.70306536 |
| 94 | MP0001661_extended_life_span | 0.69114376 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.68391961 |
| 96 | MP0004883_abnormal_blood_vessel | 0.68136525 |
| 97 | MP0004264_abnormal_extraembryonic_tissu | 0.65555955 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.65084551 |
| 99 | MP0006054_spinal_hemorrhage | 0.64420034 |
| 100 | MP0005334_abnormal_fat_pad | 0.63783263 |
| 101 | MP0009785_altered_susceptibility_to | 0.63474863 |
| 102 | MP0004130_abnormal_muscle_cell | 0.61558183 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.61291169 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.61158919 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.60563319 |
| 106 | MP0001879_abnormal_lymphatic_vessel | 0.60200771 |
| 107 | MP0005166_decreased_susceptibility_to | 0.58315879 |
| 108 | MP0003075_altered_response_to | 0.58202677 |
| 109 | MP0000249_abnormal_blood_vessel | 0.57345542 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.56006286 |
| 111 | MP0006082_CNS_inflammation | 0.55480498 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.54750557 |
| 113 | MP0005025_abnormal_response_to | 0.54057855 |
| 114 | MP0005164_abnormal_response_to | 0.53267864 |
| 115 | MP0009278_abnormal_bone_marrow | 0.53171442 |
| 116 | MP0005448_abnormal_energy_balance | 0.50433274 |
| 117 | MP0005535_abnormal_body_temperature | 0.50283991 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.49852833 |
| 119 | MP0009053_abnormal_anal_canal | 0.47336790 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.47304379 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.47119994 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.46696355 |
| 123 | MP0002796_impaired_skin_barrier | 0.42976025 |
| 124 | MP0004947_skin_inflammation | 0.42531121 |
| 125 | MP0002098_abnormal_vibrissa_morphology | 0.42437435 |
| 126 | MP0002060_abnormal_skin_morphology | 0.41877285 |
| 127 | MP0001835_abnormal_antigen_presentation | 0.41792810 |
| 128 | MP0005266_abnormal_metabolism | 0.41734364 |
| 129 | MP0008873_increased_physiological_sensi | 0.41543717 |
| 130 | MP0001243_abnormal_dermal_layer | 0.41021385 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.40170192 |
| 132 | MP0002135_abnormal_kidney_morphology | 0.38165874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.51988032 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.42533879 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.35155357 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.95035969 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.87466394 |
| 6 | Xanthomatosis (HP:0000991) | 5.81646023 |
| 7 | Prolonged bleeding time (HP:0003010) | 5.62651155 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.51491116 |
| 9 | Complement deficiency (HP:0004431) | 5.36115832 |
| 10 | Joint hemorrhage (HP:0005261) | 4.85386553 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.83020103 |
| 12 | Hypoglycemic coma (HP:0001325) | 4.57216649 |
| 13 | Purpura (HP:0000979) | 4.56883831 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55312792 |
| 15 | Petechiae (HP:0000967) | 4.53479925 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.41611369 |
| 17 | Epistaxis (HP:0000421) | 4.29672554 |
| 18 | Increased mean platelet volume (HP:0011877) | 4.23692936 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12233186 |
| 20 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.07738954 |
| 21 | Abnormal platelet volume (HP:0011876) | 4.07543049 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.07448762 |
| 23 | Epidermoid cyst (HP:0200040) | 4.01270935 |
| 24 | Abnormality of complement system (HP:0005339) | 3.97908607 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.96958522 |
| 26 | Hyperammonemia (HP:0001987) | 3.95961372 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86921389 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.82934423 |
| 29 | Ketosis (HP:0001946) | 3.82183399 |
| 30 | Fat malabsorption (HP:0002630) | 3.81150258 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75387551 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.71145364 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.62871733 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.57254977 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.56353006 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.45799485 |
| 37 | Hypoglycemic seizures (HP:0002173) | 3.43192638 |
| 38 | Decreased circulating renin level (HP:0003351) | 3.38950853 |
| 39 | Glomerulonephritis (HP:0000099) | 3.38807456 |
| 40 | Hyperglycinemia (HP:0002154) | 3.38541516 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.36186242 |
| 42 | Hyperglycinuria (HP:0003108) | 3.36054458 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30462273 |
| 44 | Myocardial infarction (HP:0001658) | 3.18818737 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.17563886 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17563886 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17105446 |
| 48 | Spontaneous hematomas (HP:0007420) | 3.09395037 |
| 49 | Abnormal platelet function (HP:0011869) | 2.96777633 |
| 50 | Impaired platelet aggregation (HP:0003540) | 2.96777633 |
| 51 | Ketoacidosis (HP:0001993) | 2.96314670 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.95202803 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.94797218 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94619765 |
| 55 | Eczematoid dermatitis (HP:0000976) | 2.92451679 |
| 56 | Acanthocytosis (HP:0001927) | 2.87926481 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.76744317 |
| 58 | Cerebral palsy (HP:0100021) | 2.75572758 |
| 59 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.75301472 |
| 60 | Polycythemia (HP:0001901) | 2.69891752 |
| 61 | Steatorrhea (HP:0002570) | 2.69528387 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.69029905 |
| 63 | Esophageal varix (HP:0002040) | 2.66973815 |
| 64 | Skin nodule (HP:0200036) | 2.64504776 |
| 65 | Spontaneous abortion (HP:0005268) | 2.63911212 |
| 66 | Ileus (HP:0002595) | 2.60241136 |
| 67 | Poikilocytosis (HP:0004447) | 2.52543734 |
| 68 | Symptomatic seizures (HP:0011145) | 2.51718021 |
| 69 | Metabolic acidosis (HP:0001942) | 2.48749118 |
| 70 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45719837 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.42789367 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42789367 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.42733635 |
| 74 | Delayed CNS myelination (HP:0002188) | 2.39824985 |
| 75 | Vascular calcification (HP:0004934) | 2.37154324 |
| 76 | Cholelithiasis (HP:0001081) | 2.33797835 |
| 77 | Gingival bleeding (HP:0000225) | 2.32922635 |
| 78 | Mitral stenosis (HP:0001718) | 2.32794629 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 2.28874689 |
| 80 | Nephritis (HP:0000123) | 2.23830854 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.21982716 |
| 82 | Menorrhagia (HP:0000132) | 2.21097756 |
| 83 | Amyloidosis (HP:0011034) | 2.20187015 |
| 84 | Ventricular fibrillation (HP:0001663) | 2.17572765 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.16654800 |
| 86 | Enlarged kidneys (HP:0000105) | 2.15556893 |
| 87 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.14552305 |
| 88 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.14552305 |
| 89 | Gout (HP:0001997) | 2.14179648 |
| 90 | Late onset (HP:0003584) | 2.13091959 |
| 91 | Chronic diarrhea (HP:0002028) | 2.12777555 |
| 92 | Malnutrition (HP:0004395) | 2.12486481 |
| 93 | Thrombophlebitis (HP:0004418) | 2.10213267 |
| 94 | Hyperglycemia (HP:0003074) | 2.10086809 |
| 95 | Irritability (HP:0000737) | 2.10001728 |
| 96 | Spastic diplegia (HP:0001264) | 2.09569793 |
| 97 | Glycosuria (HP:0003076) | 2.09470686 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 2.09470686 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.09400825 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.08996031 |
| 101 | Pancreatitis (HP:0001733) | 2.08627052 |
| 102 | Reticulocytosis (HP:0001923) | 2.07466838 |
| 103 | Lethargy (HP:0001254) | 2.06683446 |
| 104 | Increased serum ferritin (HP:0003281) | 2.06499213 |
| 105 | Nausea (HP:0002018) | 2.02912416 |
| 106 | Abnormality of renin-angiotensin system (HP:0000847) | 2.02253477 |
| 107 | Microcytic anemia (HP:0001935) | 2.01226727 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00787891 |
| 109 | Mucopolysacchariduria (HP:0008155) | 2.00787891 |
| 110 | Widely patent fontanelles and sutures (HP:0004492) | 1.99695622 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.99681322 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.99681322 |
| 113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99087536 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99087536 |
| 115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99087536 |
| 116 | Abnormal gallbladder physiology (HP:0012438) | 1.98390351 |
| 117 | Cholecystitis (HP:0001082) | 1.98390351 |
| 118 | Hyperaldosteronism (HP:0000859) | 1.96986123 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.96894181 |
| 120 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95643595 |
| 121 | Gingivitis (HP:0000230) | 1.94392757 |
| 122 | Abnormality of macrophages (HP:0004311) | 1.92385177 |
| 123 | Testicular neoplasm (HP:0010788) | 1.91678151 |
| 124 | * Abnormality of iron homeostasis (HP:0011031) | 1.91600338 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 1.91427524 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.90846229 |
| 127 | * Abnormality of transition element cation homeostasis (HP:0011030) | 1.90626440 |
| 128 | Alkalosis (HP:0001948) | 1.89415055 |
| 129 | Potter facies (HP:0002009) | 1.88253173 |
| 130 | Facial shape deformation (HP:0011334) | 1.88253173 |
| 131 | Paralysis (HP:0003470) | 1.87360361 |
| 132 | Rickets (HP:0002748) | 1.87200861 |
| 133 | Proximal tubulopathy (HP:0000114) | 1.86412334 |
| 134 | Pulmonary embolism (HP:0002204) | 1.86161777 |
| 135 | Myositis (HP:0100614) | 1.85607172 |
| 136 | Elevated alkaline phosphatase (HP:0003155) | 1.84484032 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.84273277 |
| 138 | Vomiting (HP:0002013) | 1.83591137 |
| 139 | Growth hormone excess (HP:0000845) | 1.82127903 |
| 140 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81680183 |
| 141 | Gastrointestinal infarctions (HP:0005244) | 1.80359888 |
| 142 | Bruising susceptibility (HP:0000978) | 1.79461096 |
| 143 | Opisthotonus (HP:0002179) | 1.78457479 |
| 144 | Pigmentary retinal degeneration (HP:0001146) | 1.77802287 |
| 145 | * Joint swelling (HP:0001386) | 1.76662828 |
| 146 | Arterial thrombosis (HP:0004420) | 1.73874929 |
| 147 | Gonadal dysgenesis (HP:0000133) | 1.72713573 |
| 148 | Orchitis (HP:0100796) | 1.72253224 |
| 149 | Inflammation of the large intestine (HP:0002037) | 1.70813847 |
| 150 | Recurrent abscess formation (HP:0002722) | 1.70501212 |
| 151 | Acne (HP:0001061) | 1.69840430 |
| 152 | Obstructive lung disease (HP:0006536) | 1.69801752 |
| 153 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69801752 |
| 154 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.67875358 |
| 155 | Conjunctival telangiectasia (HP:0000524) | 1.66629465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.38014168 |
| 2 | INSRR | 4.04959316 |
| 3 | ERN1 | 3.55308202 |
| 4 | FRK | 3.46614912 |
| 5 | FGFR4 | 3.02932727 |
| 6 | TIE1 | 2.95677734 |
| 7 | RIPK4 | 2.80187481 |
| 8 | TGFBR2 | 2.67161275 |
| 9 | TAOK3 | 2.63714417 |
| 10 | KDR | 2.59374668 |
| 11 | SIK1 | 2.54077483 |
| 12 | MST1R | 2.44571725 |
| 13 | MST4 | 2.40354217 |
| 14 | PIK3CG | 2.26564626 |
| 15 | TYK2 | 2.22956617 |
| 16 | PTK6 | 2.20479912 |
| 17 | GRK1 | 1.93539861 |
| 18 | MAPK15 | 1.90058281 |
| 19 | PKN2 | 1.79556243 |
| 20 | EIF2AK1 | 1.68410956 |
| 21 | MAP2K3 | 1.58228658 |
| 22 | TRIB3 | 1.57351966 |
| 23 | FLT3 | 1.55820112 |
| 24 | BMX | 1.53963886 |
| 25 | MAPK11 | 1.53008496 |
| 26 | IRAK3 | 1.48414897 |
| 27 | FER | 1.47965515 |
| 28 | SYK | 1.46372484 |
| 29 | MAP3K3 | 1.44941437 |
| 30 | CSK | 1.39191302 |
| 31 | CAMK1D | 1.37637072 |
| 32 | NEK9 | 1.37170809 |
| 33 | TBK1 | 1.35919490 |
| 34 | FES | 1.35675236 |
| 35 | MAP3K10 | 1.33388242 |
| 36 | MAP3K14 | 1.30264899 |
| 37 | IRAK4 | 1.29984282 |
| 38 | ERBB4 | 1.27071065 |
| 39 | JAK2 | 1.21831187 |
| 40 | PRKAA2 | 1.21651144 |
| 41 | PINK1 | 1.19658752 |
| 42 | MATK | 1.18326031 |
| 43 | MAP3K6 | 1.14691098 |
| 44 | TNK2 | 1.14233055 |
| 45 | MET | 1.11762678 |
| 46 | NUAK1 | 1.11242133 |
| 47 | BMPR2 | 1.09623738 |
| 48 | BLK | 1.08377506 |
| 49 | MAP3K5 | 1.07259226 |
| 50 | JAK1 | 1.06962612 |
| 51 | MAP3K2 | 1.06916561 |
| 52 | EPHB1 | 1.03789736 |
| 53 | RET | 1.02093037 |
| 54 | LATS1 | 0.99996533 |
| 55 | MAP2K2 | 0.99336125 |
| 56 | TAOK1 | 0.96894689 |
| 57 | ITK | 0.94718100 |
| 58 | TEC | 0.92817761 |
| 59 | MAPKAPK3 | 0.90052901 |
| 60 | CSF1R | 0.89918643 |
| 61 | GRK6 | 0.88124826 |
| 62 | PTK2 | 0.87449326 |
| 63 | SCYL2 | 0.85867796 |
| 64 | PRPF4B | 0.83628132 |
| 65 | PRKG2 | 0.83619014 |
| 66 | MAP2K6 | 0.83560172 |
| 67 | TXK | 0.82132950 |
| 68 | HIPK2 | 0.78630646 |
| 69 | ABL2 | 0.75110759 |
| 70 | CDK6 | 0.75054045 |
| 71 | SGK3 | 0.74910137 |
| 72 | MAP3K12 | 0.70674987 |
| 73 | IGF1R | 0.68755735 |
| 74 | CAMK1G | 0.67778656 |
| 75 | EPHA2 | 0.67658339 |
| 76 | DYRK1B | 0.67074791 |
| 77 | PDK1 | 0.66011572 |
| 78 | PIM1 | 0.65877927 |
| 79 | MAPK4 | 0.65465634 |
| 80 | EPHA3 | 0.64845830 |
| 81 | GSK3A | 0.64712013 |
| 82 | OBSCN | 0.63640352 |
| 83 | MAP2K4 | 0.62359725 |
| 84 | PIK3CA | 0.62052278 |
| 85 | MAP2K1 | 0.61618252 |
| 86 | TRPM7 | 0.61524005 |
| 87 | SGK2 | 0.60615543 |
| 88 | MAPK12 | 0.60597304 |
| 89 | IKBKE | 0.58591255 |
| 90 | PRKCQ | 0.58511419 |
| 91 | LCK | 0.58209341 |
| 92 | LMTK2 | 0.57914236 |
| 93 | PRKAA1 | 0.57890755 |
| 94 | MAP4K1 | 0.57303760 |
| 95 | AKT3 | 0.56889506 |
| 96 | ERBB2 | 0.56207229 |
| 97 | PRKCZ | 0.53904782 |
| 98 | MAPK7 | 0.53338092 |
| 99 | ACVR1B | 0.52721026 |
| 100 | STK10 | 0.52376632 |
| 101 | WNK3 | 0.51674885 |
| 102 | PRKACG | 0.51664763 |
| 103 | MYLK | 0.51266173 |
| 104 | BTK | 0.51161903 |
| 105 | IKBKB | 0.50622430 |
| 106 | CDC42BPA | 0.50435725 |
| 107 | MAPK3 | 0.50244203 |
| 108 | FGFR3 | 0.49976825 |
| 109 | MAP3K7 | 0.48847582 |
| 110 | ZAP70 | 0.47645300 |
| 111 | PTK2B | 0.47077836 |
| 112 | GRK5 | 0.46943893 |
| 113 | EGFR | 0.46763440 |
| 114 | PRKD1 | 0.45015440 |
| 115 | OXSR1 | 0.44216536 |
| 116 | RIPK1 | 0.44082013 |
| 117 | LYN | 0.43947424 |
| 118 | PBK | 0.43403218 |
| 119 | FGFR2 | 0.43397017 |
| 120 | DAPK2 | 0.40731044 |
| 121 | MAP3K11 | 0.39363807 |
| 122 | NLK | 0.37337215 |
| 123 | KIT | 0.36874321 |
| 124 | TAOK2 | 0.35973220 |
| 125 | MAP3K1 | 0.35934698 |
| 126 | PDPK1 | 0.33865047 |
| 127 | LRRK2 | 0.32747352 |
| 128 | GRK7 | 0.30598044 |
| 129 | HCK | 0.30361460 |
| 130 | FGR | 0.30285754 |
| 131 | PDGFRA | 0.28583440 |
| 132 | IRAK1 | 0.28108486 |
| 133 | JAK3 | 0.25794228 |
| 134 | STK3 | 0.25574833 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.23292024 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57006341 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32963976 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.05793339 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97516610 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93208798 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63118162 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51699965 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.48173876 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39870445 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35573004 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28958369 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25221319 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23047489 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07602099 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07198307 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.05438466 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99193889 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95164752 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90836580 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83999691 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82438733 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78327574 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74514883 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71765006 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68962157 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66837747 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.66028872 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65751972 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.65122890 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.64439028 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64246752 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53868160 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53800229 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50920378 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49840134 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48881959 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46743942 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39296084 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35419492 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27638065 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25456493 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25216965 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22015746 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.20230901 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18556432 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12171204 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08570153 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.97449111 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95026121 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93775110 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92421270 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91863564 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90080647 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87434439 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86644547 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.84504696 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83042618 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82152817 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81837528 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81211866 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77924456 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77468843 |
| 64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73471679 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69300736 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65949592 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.61799627 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61768227 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61762794 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59471815 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59185059 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58775608 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.57342404 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53886126 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49563313 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49417152 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49032356 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48177918 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48168166 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47347276 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47042766 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45808094 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45799166 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41797580 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.41402536 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40003104 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38888057 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37968711 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.35753214 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33417446 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33352961 |
| 92 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32246995 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30295458 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29653485 |
| 95 | Tuberculosis_Homo sapiens_hsa05152 | 0.28986135 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26352238 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24581714 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.24453092 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24001586 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22537763 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22374534 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22288954 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21956811 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.19769678 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18868472 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.17382315 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13879966 |
| 108 | * Mineral absorption_Homo sapiens_hsa04978 | 0.10543029 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10507868 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.08371250 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07851705 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06553933 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03843971 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.03706461 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03063745 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02117947 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01587087 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.1107245 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | -0.1073630 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1018726 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0866290 |
| 122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0814463 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0789799 |
| 124 | Malaria_Homo sapiens_hsa05144 | -0.0715728 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | -0.0681674 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0307329 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0191310 |

